Treatment of Secondary Mitral Regurgitation in Heart Failure: A Shifting Paradigm in the Wake of the COAPT Trial
Secondary mitral regurgitation (MR) is common in patients with left heart dysfunction and it is associated with poor outcomes. Findings from the Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation (COAPT) trial, pub...
Guardado en:
Autores principales: | Kelly H Schlendorf, Jared O’Leary, JoAnn Lindenfeld |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2658dea05e4b40c199171b88e74c62c1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Contemporary Management of Secondary Mitral Regurgitation
por: Kashish Goel, et al.
Publicado: (2020) -
Clinical Trial Perspective: Cost-effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients with Heart Failure and Secondary Mitral Regurgitation. Results From the COAPT Trial
por: Suzanne J Baron
Publicado: (2020) -
Disproportionate Mitral Regurgitation Determines Survival in Acute Heart Failure
por: Max Berrill, et al.
Publicado: (2021) -
Asian Pacific Society of Cardiology Consensus Recommendations on the Use of MitraClip for Mitral Regurgitation
por: Khung Keong Yeo, et al.
Publicado: (2021) -
Mitral Valve Regurgitation in two Thoroughbred Stallions
por: Pinar Orhan, et al.
Publicado: (2016)